PortfoliosLab logoPortfoliosLab logo
KPTI vs. KEEL
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

KPTI vs. KEEL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Karyopharm Therapeutics Inc. (KPTI) and Keel Infrastructure Corporation (KEEL). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, KPTI achieves a -73.91% return, which is significantly lower than KEEL's 68.94% return.


KPTI

1D
-72.61%
1M
-80.00%
6M
-70.55%
YTD
-73.91%
1Y
-51.15%
3Y*
-58.57%
5Y*
-56.62%
10Y*
-32.96%
ALL TIME*
-32.15%

KEEL

1D
-1.98%
1M
-13.51%
6M
69.66%
YTD
68.94%
1Y
242.24%
3Y*
30.65%
5Y*
-1.07%
10Y*
ALL TIME*
13.26%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$141.39M$139.45M$235.87M
$12.61M$7.85M$5.63M

KPTI vs. KEEL - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
KPTI
Karyopharm Therapeutics Inc.
-73.91%-27.45%-21.82%-74.56%-47.12%-58.46%-19.25%104.59%-48.29%
KEEL
Keel Infrastructure Corporation
68.94%57.72%-48.80%561.36%-91.29%165.79%397.66%-27.96%-64.19%

Correlation

The correlation between KPTI and KEEL is 0.11, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.11

Correlation (3Y)
Balances recent behavior with more history.

0.14

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.23

Correlation (All Time)
Calculated using the full available price history since Aug 28, 2018

0.17

The correlation between KPTI and KEEL shifts across timeframes, from 0.11 (1 year) to 0.23 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

KPTI:

$43.51M

KEEL:

$2.40B

EPS

KPTI:

-$11.39

KEEL:

-$0.51

PS Ratio

KPTI:

0.22

KEEL:

9.59

Total Revenue (TTM)

KPTI:

$151.12M

KEEL:

$229.28M

Gross Profit (TTM)

KPTI:

$145.13M

KEEL:

-$18.90M

EBITDA (TTM)

KPTI:

-$93.05M

KEEL:

-$149.60M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

KPTI vs. KEEL — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

KPTI
KPTI Risk / Return Rank: 2626
Overall Rank
KPTI Sharpe Ratio Rank: 2525
Sharpe Ratio Rank
KPTI Sortino Ratio Rank: 4141
Sortino Ratio Rank
KPTI Omega Ratio Rank: 4343
Omega Ratio Rank
KPTI Calmar Ratio Rank: 2222
Calmar Ratio Rank
KPTI Martin Ratio Rank: 00
Martin Ratio Rank

KEEL
KEEL Risk / Return Rank: 8686
Overall Rank
KEEL Sharpe Ratio Rank: 9090
Sharpe Ratio Rank
KEEL Sortino Ratio Rank: 8989
Sortino Ratio Rank
KEEL Omega Ratio Rank: 8686
Omega Ratio Rank
KEEL Calmar Ratio Rank: 8686
Calmar Ratio Rank
KEEL Martin Ratio Rank: 7878
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

KPTI vs. KEEL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Karyopharm Therapeutics Inc. (KPTI) and Keel Infrastructure Corporation (KEEL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


KPTIKEELDifference
Sharpe ratioReturn per unit of total volatility

-2.31

Sortino ratioReturn per unit of downside risk

-2.32

Omega ratioGain probability vs. loss probability

1.05

1.31

-0.26

Calmar ratioReturn relative to maximum drawdown

-0.61

2.94

-3.55

Martin ratioReturn relative to average drawdown

-2.42

4.77

-7.19

KPTI vs. KEEL - Sharpe Ratio Comparison

The current KPTI Sharpe Ratio is -0.42, which is lower than the KEEL Sharpe Ratio of 1.89. The chart below compares the historical Sharpe Ratios of KPTI and KEEL, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

KPTI vs. KEEL - Drawdown Comparison

The maximum KPTI drawdown since its inception was -99.73%, roughly equal to the maximum KEEL drawdown of -95.72%. Use the drawdown chart below to compare losses from any high point for KPTI and KEEL.


Loading charts...

Drawdown Indicators


KPTIKEELDifference

Max Drawdown

Largest peak-to-trough decline

-99.73%

-95.72%

-4.01%

Max Drawdown (1Y)

Largest decline over 1 year

-82.01%

-73.65%

-8.36%

Max Drawdown (3Y)

Largest decline over 3 years

-92.73%

-81.04%

-11.69%

Max Drawdown (5Y)

Largest decline over 5 years

-99.11%

-95.72%

-3.39%

Max Drawdown (10Y)

Largest decline over 10 years

-99.54%

Current Drawdown

Current decline from peak

-99.73%

-55.24%

-44.49%

Average Drawdown

Average peak-to-trough decline

-75.59%

-67.10%

-8.49%

Ulcer Index

Depth and duration of drawdowns from previous peaks

20.49%

45.31%

-24.82%

Volatility

KPTI vs. KEEL - Volatility Comparison

Karyopharm Therapeutics Inc. (KPTI) has a higher volatility of 131.26% compared to Keel Infrastructure Corporation (KEEL) at 42.99%. This indicates that KPTI's price experiences larger fluctuations and is considered to be riskier than KEEL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


KPTIKEELDifference

Volatility (1M)

Calculated over the trailing 1-month period

131.26%

42.99%

+88.27%

Volatility (6M)

Calculated over the trailing 6-month period

144.90%

78.09%

+66.81%

Volatility (1Y)

Calculated over the trailing 1-year period

117.57%

114.73%

+2.84%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

101.03%

105.23%

-4.20%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

89.78%

289.01%

-199.23%

Dividends

KPTI vs. KEEL - Dividend Comparison

Neither KPTI nor KEEL has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

KPTI vs. KEEL - Financials Comparison

This section allows you to compare key financial metrics between Karyopharm Therapeutics Inc. and Keel Infrastructure Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


KPTI and KEEL have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

KPTI has higher volatility (131.26%) compared to KEEL (42.99%). In terms of maximum drawdown, KPTI dropped -99.73% vs KEEL's -95.72%.

KEEL currently has the higher Sharpe Ratio (1.89 vs -0.42), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for KPTI and KEEL

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer